BeStock  
Markets › Compare › TVTX vs BLTE

TVTX vs BLTE

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
TVTX · Travere Therapeutic$47.00 ▼ 2.69%
BLTE · Belite Bio$127.38 ▼ 15.65%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

68100132164195Nov 24, '25May 26, '26Nov 20, '26
  • TVTX +31.3%
  • BLTE -6.3%

Head to head

MetricTVTXBLTE
Price$47.00$127.38
Change today▼ 2.69%▼ 15.65%
Market cap$4.51B$5.17B
Return, 3 months-27.9%-19.8%
Return, year to date+23.0%-20.4%
Return, 1 year+35.5%+5.7%
P/E (TTM)––
P/B200.06.7
P/E percentile vs own 5y15th40th
Dividend yield––
Revenue growth (YoY, latest qtr)+36.2%–
Net profit growth (YoY)-303.6%-39.6%
Gross margin98.8%–
Operating margin-3.1%–
Net margin-18.7%–
Return on equity-252.7%-21.2%
Analyst target vs. price+56.2%+81.9%
Analyst buy share91%100%
RSI (14)3532
30-day volatility45.1%74.4%
Max drawdown, 1 year-33.5%-34.2%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BLTE is the largest of the group by market value.
  • TVTX has returned the most over the past year.
  • TVTX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top